Patents by Inventor Preben Olesen

Preben Olesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100075932
    Abstract: Novel salicylic anilides are chemical uncouplers useful e.g. for the treatment of obesity.
    Type: Application
    Filed: November 24, 2009
    Publication date: March 25, 2010
    Applicant: HIGH POINT PHARMACEUTICALS, LLC
    Inventors: Preben Olesen, Thomas Kruse Hansen, Lise Brown Christiansen, Holger Claus Hansen
  • Publication number: 20070010559
    Abstract: Novel 3-vinylsulfonyl indole derivatives are chemical uncouplers useful e.g. for treatment of obesity.
    Type: Application
    Filed: May 25, 2006
    Publication date: January 11, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Lise Christiansen, Tina Tagmose, Preben Olesen, Thomas Hansen
  • Publication number: 20070004794
    Abstract: Novel salicylic anilides are chemical uncouplers useful e.g. for the treatment of obesity.
    Type: Application
    Filed: May 25, 2006
    Publication date: January 4, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Preben Olesen, Thomas Hansen, Lise Christiansen, Holger Hansen
  • Publication number: 20070004799
    Abstract: A compound according to formula I wherein R1 and R2 independently represent hydrogen, nitro, cyano, halogen, alkyl, alkenyl, alkynyl, haloalkyl, aralkyl, heteroaralkyl, alkoxy, alkylamino, —C(O)O—R4, —C(O)NR5R6, —S(O)2OR4, S(O)2NR5R6 or —S(O)nR4; R4 represents alkyl, alkenyl, alkynyl, haloalkyl, hydroxyalkyl, cycloalkyl or aryl, wherein said aryl may optionally be substituted with one or more substituents selected from alkyl, halogen, haloalkyl, hydroxyalkyl, cyano, nitro or —(CH2)a—NR7R8; R5 and R6 independently represent hydrogen alkyl, alkenyl, alkynyl, haloalkyl, hydroxyalkyl, cycloalkyl or aryl, wherein said aryl may optionally be substituted with one or more substituents selected from alkyl, alkoxy, halogen, haloalkyl, hydroxyalkyl, cyano, nitro or —(CH2)a—NR7R8; or R5 and R6 together with said nitrogen atom they are attached form a cycloalkyl or heterocyclyl ring, optionally substituted with one or more alkyl substituents; R7 and R8 independently represents hydrogen, alkyl; or R7 and R8 together with s
    Type: Application
    Filed: May 24, 2006
    Publication date: January 4, 2007
    Applicant: Novo Nordisk A/S
    Inventor: Preben Olesen
  • Publication number: 20060128662
    Abstract: Novel hydroxyl styrene sulfonyl derivatives of Formula (I) are provided which are useful in the treatment of obesity.
    Type: Application
    Filed: November 9, 2005
    Publication date: June 15, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Tina Tagmose, Preben Olesen, Thomas Hansen
  • Patent number: 6127368
    Abstract: Compounds of formula I ##STR1## are described, as well as the process for their production and their use in pharmaceutical agents.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: October 3, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Dieter Seidelmann, Andreas Huth, Preben Olesen, Eckhard Ottow, Jonathan Turner, Margrit Hillmann, Belinda Cole
  • Patent number: 5968926
    Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 19, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Franklin Porter Bymaster, Harlan E. Shannon, Per Sauerberg, Preben Olesen, John Stanley Ward, Charles H. Mitch
  • Patent number: 5574043
    Abstract: The present invention relates to therapeutically active azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: November 12, 1996
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Preben Olesen